vs
Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and BlueLinx Holdings Inc. (BXC). Click either name above to swap in a different company.
Alignment Healthcare, Inc. is the larger business by last-quarter revenue ($1.0B vs $748.9M, roughly 1.4× BlueLinx Holdings Inc.). BlueLinx Holdings Inc. runs the higher net margin — 0.2% vs -1.1%, a 1.3% gap on every dollar of revenue. On growth, Alignment Healthcare, Inc. posted the faster year-over-year revenue change (44.4% vs 0.2%). BlueLinx Holdings Inc. produced more free cash flow last quarter ($52.7M vs $-55.4M). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (26.9% CAGR vs 2.5%).
Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.
BlueLinx Holdings Inc. is a wholesale distributor of building and industrial products in the United States. Headquartered in Atlanta, Georgia, Shyam Reddy serves as its President and CEO.
ALHC vs BXC — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.0B | $748.9M |
| Net Profit | $-11.0M | $1.7M |
| Gross Margin | — | 14.4% |
| Operating Margin | -1.0% | 1.3% |
| Net Margin | -1.1% | 0.2% |
| Revenue YoY | 44.4% | 0.2% |
| Net Profit YoY | 64.6% | -89.7% |
| EPS (diluted) | $-0.04 | $0.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.0B | — | ||
| Q3 25 | $993.7M | $748.9M | ||
| Q2 25 | $1.0B | $780.1M | ||
| Q1 25 | $926.9M | $709.2M | ||
| Q4 24 | $701.2M | $710.6M | ||
| Q3 24 | $692.4M | $747.3M | ||
| Q2 24 | $681.3M | $768.4M | ||
| Q1 24 | $628.6M | $726.2M |
| Q4 25 | $-11.0M | — | ||
| Q3 25 | $3.7M | $1.7M | ||
| Q2 25 | $15.7M | $4.3M | ||
| Q1 25 | $-9.1M | $2.8M | ||
| Q4 24 | $-31.1M | — | ||
| Q3 24 | $-26.4M | $16.0M | ||
| Q2 24 | $-24.0M | $14.3M | ||
| Q1 24 | $-46.5M | $17.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | 14.4% | ||
| Q2 25 | — | 15.3% | ||
| Q1 25 | — | 15.7% | ||
| Q4 24 | — | 15.9% | ||
| Q3 24 | — | 16.8% | ||
| Q2 24 | — | 15.9% | ||
| Q1 24 | — | 17.6% |
| Q4 25 | -1.0% | — | ||
| Q3 25 | 0.8% | 1.3% | ||
| Q2 25 | 2.2% | 1.9% | ||
| Q1 25 | -0.6% | 1.5% | ||
| Q4 24 | -3.2% | 1.7% | ||
| Q3 24 | -2.8% | 3.2% | ||
| Q2 24 | -2.7% | 3.1% | ||
| Q1 24 | -6.5% | 3.8% |
| Q4 25 | -1.1% | — | ||
| Q3 25 | 0.4% | 0.2% | ||
| Q2 25 | 1.5% | 0.6% | ||
| Q1 25 | -1.0% | 0.4% | ||
| Q4 24 | -4.4% | — | ||
| Q3 24 | -3.8% | 2.1% | ||
| Q2 24 | -3.5% | 1.9% | ||
| Q1 24 | -7.4% | 2.4% |
| Q4 25 | $-0.04 | — | ||
| Q3 25 | $0.02 | $0.20 | ||
| Q2 25 | $0.07 | $0.54 | ||
| Q1 25 | $-0.05 | $0.33 | ||
| Q4 24 | $-0.15 | $0.67 | ||
| Q3 24 | $-0.14 | $1.87 | ||
| Q2 24 | $-0.13 | $1.65 | ||
| Q1 24 | $-0.25 | $2.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $604.2M | $429.4M |
| Total DebtLower is stronger | $323.2M | $598.5M |
| Stockholders' EquityBook value | $179.3M | $623.0M |
| Total Assets | $1.1B | $1.6B |
| Debt / EquityLower = less leverage | 1.80× | 0.96× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $604.2M | — | ||
| Q3 25 | $644.1M | $429.4M | ||
| Q2 25 | $503.8M | $386.8M | ||
| Q1 25 | $479.5M | $449.0M | ||
| Q4 24 | $470.6M | $505.6M | ||
| Q3 24 | $381.0M | $526.3M | ||
| Q2 24 | $363.7M | $491.4M | ||
| Q1 24 | $301.7M | $481.3M |
| Q4 25 | $323.2M | — | ||
| Q3 25 | $322.7M | $598.5M | ||
| Q2 25 | $322.3M | $596.4M | ||
| Q1 25 | $321.9M | $596.6M | ||
| Q4 24 | $321.4M | $575.1M | ||
| Q3 24 | $212.0M | $576.0M | ||
| Q2 24 | $211.7M | $574.6M | ||
| Q1 24 | $162.0M | $574.0M |
| Q4 25 | $179.3M | — | ||
| Q3 25 | $161.9M | $623.0M | ||
| Q2 25 | $141.0M | $621.3M | ||
| Q1 25 | $108.1M | $636.1M | ||
| Q4 24 | $99.9M | $646.4M | ||
| Q3 24 | $114.5M | $655.6M | ||
| Q2 24 | $123.7M | $652.3M | ||
| Q1 24 | $130.9M | $653.2M |
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.1B | $1.6B | ||
| Q2 25 | $1.0B | $1.6B | ||
| Q1 25 | $895.6M | $1.6B | ||
| Q4 24 | $782.1M | $1.6B | ||
| Q3 24 | $692.3M | $1.6B | ||
| Q2 24 | $716.3M | $1.6B | ||
| Q1 24 | $633.2M | $1.6B |
| Q4 25 | 1.80× | — | ||
| Q3 25 | 1.99× | 0.96× | ||
| Q2 25 | 2.29× | 0.96× | ||
| Q1 25 | 2.98× | 0.94× | ||
| Q4 24 | 3.22× | 0.89× | ||
| Q3 24 | 1.85× | 0.88× | ||
| Q2 24 | 1.71× | 0.88× | ||
| Q1 24 | 1.24× | 0.88× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-50.4M | $58.6M |
| Free Cash FlowOCF − Capex | $-55.4M | $52.7M |
| FCF MarginFCF / Revenue | -5.5% | 7.0% |
| Capex IntensityCapex / Revenue | 0.5% | 0.8% |
| Cash ConversionOCF / Net Profit | — | 35.42× |
| TTM Free Cash FlowTrailing 4 quarters | $113.1M | $-25.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-50.4M | — | ||
| Q3 25 | $144.6M | $58.6M | ||
| Q2 25 | $29.1M | $-26.8M | ||
| Q1 25 | $16.6M | $-33.9M | ||
| Q4 24 | $-8.7M | $18.7M | ||
| Q3 24 | $26.2M | $61.8M | ||
| Q2 24 | $23.5M | $35.8M | ||
| Q1 24 | $-6.2M | $-31.1M |
| Q4 25 | $-55.4M | — | ||
| Q3 25 | $139.1M | $52.7M | ||
| Q2 25 | $21.1M | $-36.4M | ||
| Q1 25 | $8.4M | $-39.8M | ||
| Q4 24 | $-18.0M | $-1.5M | ||
| Q3 24 | $16.9M | $53.8M | ||
| Q2 24 | $11.8M | $29.3M | ||
| Q1 24 | $-17.4M | $-36.6M |
| Q4 25 | -5.5% | — | ||
| Q3 25 | 14.0% | 7.0% | ||
| Q2 25 | 2.1% | -4.7% | ||
| Q1 25 | 0.9% | -5.6% | ||
| Q4 24 | -2.6% | -0.2% | ||
| Q3 24 | 2.4% | 7.2% | ||
| Q2 24 | 1.7% | 3.8% | ||
| Q1 24 | -2.8% | -5.0% |
| Q4 25 | 0.5% | — | ||
| Q3 25 | 0.6% | 0.8% | ||
| Q2 25 | 0.8% | 1.2% | ||
| Q1 25 | 0.9% | 0.8% | ||
| Q4 24 | 1.3% | 2.9% | ||
| Q3 24 | 1.3% | 1.1% | ||
| Q2 24 | 1.7% | 0.8% | ||
| Q1 24 | 1.8% | 0.8% |
| Q4 25 | — | — | ||
| Q3 25 | 38.77× | 35.42× | ||
| Q2 25 | 1.86× | -6.21× | ||
| Q1 25 | — | -12.09× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.86× | ||
| Q2 24 | — | 2.50× | ||
| Q1 24 | — | -1.78× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALHC
Segment breakdown not available.
BXC
| Specialty Products | $525.5M | 70% |
| Structural Products | $223.4M | 30% |
